Description
Bremelanotide is a melanocortin receptor agonist with an authorised medical use in specific jurisdictions and circumstances. The regulatory status and identity of the actual product must be established before describing it as a medicine or making treatment claims.
Technical Specifications
- Product Name: PT-141 (Bremelanotide)
- Product Classification: Bremelanotide Peptide, as labelled
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Molecular Weight: Approximately 1,025 Da
- Purity: ≥98% HPLC, as stated on the supplied label
- Form: Lyophilized powder
- Appearance: White to off-white, as labelled
- CAS Number: 189691-06-3
- Labelled Pack: 6 mg/vial; 1 vial
Quality Documentation
Refer to the applicable batch-specific analytical report and verify the product’s regulatory status in the relevant jurisdiction.
Storage and Handling
Follow the approved, product-specific storage and safety documentation.
*Notice:* Do not make unsupported claims concerning sexual function, libido or treatment outcomes. Do not imply that a research-labelled product is an approved pharmaceutical presentation.
Reviews
There are no reviews yet.